← All companies

GLPG

Lakefront Biotherapeutics NV

GLPGF Nasdaq Pharmaceutical Preparations EDGAR ↗

$48.70

+20.62 +73.43%

Key statistics

from XBRL data in SEC filings

Market cap

$3.21B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$26.20 – $34.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 28, 2026 6-K FORM 6-K Jul 21, 2026 6-K FORM 6-K Jul 15, 2026 6-K FORM 6-K Jul 13, 2026 6-K FORM 6-K Jul 7, 2026 6-K FORM 6-K Jun 30, 2026 6-K FORM 6-K Jun 30, 2026 6-K FORM 6-K Jun 24, 2026 6-K FORM 6-K Jun 16, 2026 6-K FORM 6-K Jun 9, 2026 6-K FORM 6-K Jun 9, 2026 6-K FORM 6-K Jun 5, 2026 6-K FORM 6-K May 27, 2026 6-K FORM 6-K May 6, 2026 6-K FORM 6-K Apr 29, 2026 6-K Mar 31, 2026 6-K Mar 30, 2026 20-F Mar 26, 2026 6-K FORM 6-K Mar 24, 2026 6-K FORM 6-K Mar 17, 2026 6-K FORM 6-K Mar 10, 2026 6-K FORM 6-K Mar 6, 2026 6-K FORM 6-K Mar 5, 2026 6-K FORM 6-K Mar 4, 2026 6-K FORM 6-K Feb 23, 2026 6-K FORM 6-K Feb 19, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Jan 5, 2026 6-K FORM 6-K Dec 18, 2025 6-K FORM 6-K Dec 8, 2025 6-K FORM 6-K Nov 26, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 30, 2025 6-K FORM 6-K Oct 24, 2025 6-K FORM 6-K Oct 21, 2025 6-K FORM 6-K Oct 16, 2025 6-K FORM 6-K Oct 1, 2025 6-K FORM 6-K Aug 7, 2025